Endovascular treatment of the vertebral artery origin stenosis by using the closed-cell,self-expandable Carotid Wallstent

Abstract

Background

Endovascular treatment has been considered a good alternative to surgery for symptomatic vertebral artery origin stenosis (VAOS) due to the high risk of morbidity associated with surgery. The purpose of this study was to evaluate the feasibility and efficacy of insertion of the closed-cell, self-expandable Carotid Wallstent for the treatment of VAOS.

Methods

The records of 72 patients with VAOS refractory to adequate medication who were treated by endovascular treatment with the Carotid Wallstent from December 2006 to November 2018 were retrospectively evaluated.

Results

Of the 72 patients, 43 presented with transient ischemic attacks. Forty-seven patients (65.3%) manifested other brachiocephalic stenoses; of these, 40 patients had occlusion, hypoplasia, or stenosis of the contralateral vertebral artery. Overall technical success (defined as 20% or less residual stenosis) was 100%. Procedure-related complications (n = 8, 11.1%) included sudden asystole (n = 1), acute in-stent thrombosis (n = 3), minor stroke (n = 3), and stent shortening (n = 1). All complications were resolved without permanent neurological deficit. Angiographic follow-up (mean, 13.0 months) was achieved in 49 patients and revealed in-stent restenosis in 1 patient (2.0%) and stent malposition by shortening in 2 patients (4.1%). Follow-up records were available in 57 patients (mean 15.6 months). Three of the 57 patients (n = 3, 5.3%) had recurrent symptoms of vertebrobasilar ischemia and none was retreated.

Conclusions

Endovascular treatment of symptomatic VAOS using the closed-cell, self-expandable Carotid Wallstent is technically feasible and effective in alleviating patient symptoms and for improving vertebrobasilar blood flow.

Keywords

Stent vertebral artery vertebrobasilar insufficiency

Get full access to this article

View all access options for this article.

References

Caplan

Amarenco

Rosengart

, et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992; 42: 1505–1512.

Wityk

Chang

Rosengart

, et al. Proximal extracranial vertebral artery disease in the New England medical center posterior circulation registry. Arch Neurol 1998; 55: 470–478.

Caplan

Wityk

Glass

, et al. New England medical center posterior circulation registry. Ann Neurol 2004; 56: 389–398.

Marquardt

Kuker

Chandratheva

, et al. Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain 2009; 132: 982–988.

Gulli

Marquardt

Rothwell

, et al. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke 2013; 44: 598–604.

Jenkins

Stewart

Endovascular treatment of vertebral artery stenosis.

Prog Cardiovasc Dis 2017; 59: 619–625.

Markus

Larsson

Kuker

, et al. Stenting for symptomatic vertebral artery stenosis: the Vertebral Artery Ischaemia Stenting Trial. Neurology 2017; 89: 1229–1236.

Henry

Amor

Klonaris

, et al. Angioplasty and stenting of the extracranial carotid arteries. Tex Heart Inst J 2000; 27: 150–158.

Lin

Hung

Tseng

WYI

, et al. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc 2008; 107: 253–258.

10.

Moufarrij

Little

Furlan

, et al. Vertebral artery stenosis: long-term follow-up. Stroke 1984; 15: 260–263.

11.

Imparato

Riles

Kim

GE.

Cervical vertebral angioplasty for brain stem ischemia. Surgery 1981; 90: 842–852.

12.

Albuquerque

Fiorella

Han

, et al. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery 2003; 53: 607–614; discussion 614-606.

13.

Tsutsumi

Kazekawa

Onizuka

, et al. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology 2007; 49: 253–257

14.

Lederman

Mendelsohn

Santos

, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001; 142: 314–323.

15.

Tsunoda

Nakamura

Wada

, et al. Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 2004; 15: 39–44.

16.

Sullivan

Ainsworth

Langan

, et al. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis. J Vasc Surg 2002; 36: 143–149.

17.

Venkatraman

Poh

Vinalia

, et al. Collapse pressures of biodegradable stents. Biomaterials 2003; 24: 2105–2111.

18.

Kim

Baik

Yoo

, et al. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique. Report of two cases. J Neurosurg 2007; 106: 907–911.

19.

Kreutzer

Rome

JJ.

Open-cell design stents in congenital heart disease: a comparison of IntraStent vs. Palmaz stents. Catheter Cardiovasc Interv 2002; 56: 400–409.

20.

Aikawa

Nagata

Onizuka

, et al. Shortening of Wallstent RP during carotid artery stenting requires appropriate stent placement. Neurol Med Chir (Tokyo) 2008; 48: 249–252; discussion 252-243.

21.

Yoon

Baik

, et al. Delayed Carotid Wallstent shortening resulting in restenosis following successful carotid artery angioplasty and stenting. J Korean Neurosurg Soc 2009; 46: 495–497.

22.

Akins

Kerber

Pakbaz

RS.

Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series.

J Invasive Cardiol 2008; 20: 14–20.

23.

Dabus

Gerstle

Derdeyn

, et al. Endovascular treatment of the vertebral artery origin in patients with symptoms of vertebrobasilar ischemia. Neuroradiology 2006; 48: 917–923.

24.

Natarajan

Ogilvy

Yang

, et al. Restenosis rates following vertebral artery origin stenting: does stent type make a difference? J Neurosurg 2010; 113: A413–A413.

25.

Weber

Mayer

Henkes

, et al. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol 2005; 56: 240–247.

26.

Schillinger

Gschwendtner

Reimers

, et al. Does carotid stent cell design matter? Stroke 2008; 39: 905–909.

27.

Geng

Hussain

, et al. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial. J Endovasc Ther 2015; 22: 436–444.

28.

Qureshi

Kirmani

Harris-Lane

, et al. Vertebral artery origin stent placement with distal protection: technical and clinical results. Am J Neuroradiol 2006; 27: 1140–1145.

29.

Wehman

Hanel

Guidot

, et al. Atherosclerotic occlusive extracranial vertebral artery disease: indications for intervention, endovascular techniques, short-term and long-term results. J Interv Cardiol 2004; 17: 219–232.

30.

Park

Fiorella

Stiefel

, et al. Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents. Neurosurgery 2010; 67: 41–48; discussion 48.

31.

Ellis

Colombo

Grube

, et al. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol 2007; 49: 1043–1051.